Prosecution Insights
Last updated: April 19, 2026
Application No. 18/247,530

PHOTOSTABLE COMPOSITION AND METHOD OF REDUCING OR CONTROLLING WEED POPULATION APPLYING SAID COMPOSITION

Final Rejection §103
Filed
Mar 31, 2023
Examiner
WERTZ, ASHLEE ELIZABETH
Art Unit
1612
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
UPL Corporation Limited
OA Round
2 (Final)
41%
Grant Probability
Moderate
3-4
OA Rounds
3y 7m
To Grant
80%
With Interview

Examiner Intelligence

Grants 41% of resolved cases
41%
Career Allow Rate
13 granted / 32 resolved
-19.4% vs TC avg
Strong +39% interview lift
Without
With
+39.3%
Interview Lift
resolved cases with interview
Typical timeline
3y 7m
Avg Prosecution
59 currently pending
Career history
91
Total Applications
across all art units

Statute-Specific Performance

§103
49.5%
+9.5% vs TC avg
§102
5.9%
-34.1% vs TC avg
§112
18.7%
-21.3% vs TC avg
Black line = Tech Center average estimate • Based on career data from 32 resolved cases

Office Action

§103
DETAILED ACTION Examiner’s Note In the remarks filed 02/24/2026 the applicant states that claims 1-6, 8-10, 14, 15, and 20 remain pending for further examination. It appears that claim 15 was inadvertently marked as withdrawn in the claims filed 02/24/2026. The Examiner has examined claim 15 as it is drawn to the elected Group I. Previous Rejections Applicant’s arguments, filed February 24, 2026, have been fully considered. Rejections and/or objections not reiterated from previous office actions are hereby withdrawn. The following rejections and/or objections are either reiterated or newly applied. They constitute the complete set presently being applied to the instant application. Claim Rejections - 35 USC § 103 (New, Necessitated by Amendment) The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. Claims 1-3, 5-6, 8-10, 14, and 20 are rejected under 35 U.S.C. 103 as being as being obvious over Ishaque et al. (US 8,404,263 B2) in view of Brandhorst et al (WO 2020/201657 A1 with a foreign translation provided by US 2022/0176427 A1). Regarding claims 1-3 Ishaque discloses an agrochemical formulation comprising a pesticide (such as the triazolone herbicide, amicarbazone (Col 12, line 38)) an organic UV photoprotective filter, and metal oxide nanoparticles (Abstract). Ishaque discloses the total amount of organic UV photoprotective filter in the agrochemical formulation is from 0.5 to 30 wt. % (Col 6, lines 24-26) and the total amount of metal oxide nanoparticles in the agrochemical formulation is from 0.5 to 20 wt.% (Col 5, lines 31-33). Ishaque discloses that the formulation is contacted with soil (abstract; Col 16, lines 16-21). Ishaque does not disclose epoxidized vegetable oil. Brandhorst discloses a composition for soil with an epoxidized vegetable oil (abstract). The composition includes the epoxidized vegetable oil in an amount of 1-100 wt.% [0085]. Brandhorst teaches that the epoxidized vegetable oil acts as a carbon source in soil to help biologically degrade polluting substances [0043]-[0047]. Since Ishaque generally teaches a composition for soil, it would have been prima facie obvious to one of ordinary skill in the art to include epoxidized vegetable oil, in the amount taught by Brandhorst, within the teachings of Ishaque, because Brandhorst teaches epoxidized vegetable oil in a composition for the soil. An ordinarily skilled artisan would be motivated to use epoxidized vegetable oil because Brandhorst teaches that the epoxidized vegetable oil acts as a carbon source in soil to help biologically degrade polluting substances [0043]-[0047]. In regards to the amount of the photoprotective agent, in the case where the claimed ranges “overlap or lie inside ranges disclosed by the prior art” a prima facie case of obviousness exists. See MPEP 2144.05 A. Claim 5 is rendered prima facie obvious because Ishaque discloses the photoprotective filters to be UV-A and UV-B filters (Col 5, lines 41-43). Claim 6 is rendered prima facie obvious because Ishaque discloses the metal oxide nanoparticles are particularly preferred to be titanium dioxide (Col 2, lines 38-39). Claims 8 and 9 are rendered prima facie obvious because Ishaque discloses the composition additionally includes agrochemically suitable excipients, such as adjuvants (Col 7, lines 60-67). Claim 10 is rendered prima facie obvious because Ishaque discloses the composition is stable towards light (Col 20, lines 20-29). Regarding claim 14, Ishaque discloses a photostable (Col 20, lines 20-29) agrochemical formulation comprising a pesticide (such as the triazolone herbicide, amicarbazone (Col 12, line 38)) an organic UV photoprotective filter, and metal oxide nanoparticles (Abstract). Ishaque discloses the total amount of organic UV photoprotective filter in the agrochemical formulation is from 0.5 to 30 wt. % (Col 6, lines 24-26) and the total amount of metal oxide nanoparticles in the agrochemical formulation is from 0.5 to 20 wt.% (Col 5, lines 31-33). Ishaque does not disclose epoxidized vegetable oil. Brandhorst discloses a composition for soil with an epoxidized vegetable oil (abstract). The composition includes the epoxidized vegetable oil in an amount of 1-100 wt.% [0085]. Brandhorst teaches that the epoxidized vegetable oil acts as a carbon source in soil to help biologically degrade polluting substances [0043]-[0047]. It would have been prima facie obvious to include epoxidized vegetable oil, as taught by Brandhorst, within the teachings of Ishaque, as previously discussed. In regards to the amount of photoprotective agent, a prima facie case of obviousness exists because of overlap, as previously discussed. Regarding claim 20, Ishaque discloses a kit of parts, comprising as separate components a pesticide (such as the triazolone herbicide, amicarbazone, Col 12, line 38) and additional active compounds (Col 15, lines 26-57). Ishaque teaches that the kit of parts allows for the components to be applied either together or separately from each other to deliver an effective amount of the components (Col 1, lines 16-26; Col 15, line 24-49). Ishaque does not disclose epoxidized vegetable oil. Brandhorst discloses a composition for soil with an epoxidized vegetable oil (abstract). Brandhorst teaches that the epoxidized vegetable oil acts as a carbon source in soil to help biologically degrade polluting substances [0043]-[0047]. It would have been prima facie obvious to include epoxidized vegetable oil, as taught by Brandhorst, within the teachings of Ishaque, as previously discussed and one would be motivated to include the epoxidized vegetable oil as a separate component because Ishaque teaches that a kit of parts where the pesticide and additional active compounds are separated allows for the components to be applied either together or separately to deliver an effective amount of the components (Col 1, lines 16-26; Col 15, line 24-49). Claims 4 and 15 are rejected under 35 U.S.C. 103 as being as being obvious over Ishaque et al. (US 8,404,263 B2) in view of Brandhorst et al (WO 2020/201657 A1 with a foreign translation provided by US 2022/0176427 A1) and further in view of Nogueira et al. (US 2017/0223961 A1). The 35 U.S.C. 103 rejection over Ishaque in view of Brandhorst was previously discussed. Ishaque does not disclose the composition includes 20 g/L to 1000 g/L of triazolone herbicide, as recited in claim 4, or 20 g/L to 1000 g/L of amicarbazone, as recited in claim 15. Nogueira discloses a formula comprising a triazolone herbicide pesticide, such as amicarbazone [Claim 1] in an amount of 35 g/L to 500 g/L [Claim 8]. Nogueira teaches that a formulation with this amount of triazolinone herbicide is effective in controlling weeds thereby providing a faster initial development of the crop, providing higher production levels, and increasing crop yield [Abstract] [0024] [0026]. Since Ishaque generally teaches an agrochemical formulation comprising a pesticide (such as the triazolone herbicide, amicarbazone), it would have been prima facie obvious to one of ordinary skill in the art to include the triazolone herbicide, amicarbazone, in the amount taught by Nogueira, within the teachings of Ishaque, because Nogueira teaches this amount of triazolone herbicide in an agrochemical formulation. An ordinarily skilled artisan would be motivated to use 35 g/L to 500 g/L of the triazolone herbicide, amicarbazone, because Nogueira teaches that a formulation with this amount of triazolone herbicide is effective in controlling weeds thereby providing a faster initial development of the crop, providing higher production levels, and increasing crop yield [Abstract] [0024] [0026]. A prima facie case of obviousness exists because of overlap, as previously discussed. Response to Arguments Applicant’s arguments with respect to claims 1, 14, and 20 have been considered but are moot because the new ground of rejection does not rely on any reference applied in the prior rejection of record for any teaching or matter specifically challenged in the argument. Conclusion Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Correspondence Any inquiry concerning this communication or earlier communications from the examiner should be directed to Ashlee E Wertz whose telephone number is (571)270-7663. The examiner can normally be reached Monday - Friday, 8 AM - 5 PM. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Sahana Kaup can be reached at 571-272-6897. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /ASHLEE E WERTZ/Examiner , Art Unit 1612 /SAHANA S KAUP/Supervisory Primary Examiner, Art Unit 1612
Read full office action

Prosecution Timeline

Mar 31, 2023
Application Filed
Aug 25, 2025
Non-Final Rejection — §103
Feb 24, 2026
Response Filed
Mar 13, 2026
Final Rejection — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12600822
METHOD FOR PREPARATION OF SUCCINYLATED COLLAGEN-FIBRINOGEN HYDROGEL
2y 5m to grant Granted Apr 14, 2026
Patent 12595212
TWO-STAGE SINTERING METHOD FOR PREPARING POROUS BIPHASIC CALCIUM PHOSPHATE CERAMIC FROM CALCIUM-CONTAINING BIOLOGICAL WASTE
2y 5m to grant Granted Apr 07, 2026
Patent 12590003
GRAPHENE OXIDE MATERIAL AND METHOD FOR THE PRODUCTION THEREOF
2y 5m to grant Granted Mar 31, 2026
Patent 12569423
AMYLOSE/CAROTENOIDS COMPLEXATION PROCESS
2y 5m to grant Granted Mar 10, 2026
Patent 12544446
Printed Delivery Device Having Supplements
2y 5m to grant Granted Feb 10, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

3-4
Expected OA Rounds
41%
Grant Probability
80%
With Interview (+39.3%)
3y 7m
Median Time to Grant
Moderate
PTA Risk
Based on 32 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month